Skip to content

Drug interactions

Enzalutamide + Roflumilast

Severity: Major

Enzalutamide and Roflumilast: major interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Enzalutamide is a strong CYP3A4 inducer and can reduce roflumilast and N-oxide exposure, potentially diminishing therapeutic benefit.

What this interaction means in plain words

Enzalutamide and Roflumilast can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.

Enzalutamide belongs to Endocrine; Roflumilast belongs to Respiratory.

Evidence level: Moderate

Why it happens

CYP3A4 induction by enzalutamide increases roflumilast clearance.

What to do

Avoid the combination where possible and use an alternative COPD agent. Monitor for loss of exacerbation control if both are continued.

What to ask your pharmacist

  • Does the benefit of taking both outweigh the risk in my case?
  • Do I need any blood test, ECG or other check while on both?
  • What early warning signs should I watch for, and what should I do if they appear?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Enzalutamide and Roflumilast, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Enzalutamide with Roflumilast?

MediHelp rates the interaction as major. Enzalutamide and Roflumilast can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Enzalutamide is a strong CYP3A4 inducer and can reduce roflumilast and N-oxide exposure, potentially diminishing therapeutic benefit.

How serious is the interaction between Enzalutamide and Roflumilast?

MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Avoid the combination where possible and use an alternative COPD agent. Monitor for loss of exacerbation control if both are continued.

What other medicines interact with Roflumilast?

MediHelp also lists interactions of Roflumilast with, for example, Apalutamide, Carbamazepine, Efavirenz. The full list is on the Roflumilast page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in